Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 5 | 4 | 0 | 1 | €48.72 | €54.10 | 11.039% |
| Fresenius SE & Co. KGaA | 4 | 1 | 1 | 1 | €33.41 | €38.00 | 13.738% |
| Humana Inc. | 26 | 1 | 3 | 1 | €215.40 | €372.81 | 73.077% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €3.12 | €5.55 | 78.000% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.20 | €1.84 | 824.975% |
| Dexcom Inc. | 25 | 0 | 0 | 0 | €62.54 | €115.81 | 85.177% |
| Evolus Inc | 17 | 0 | 1 | 0 | €14.80 | €20.46 | 38.258% |
| Alkermes plc | 18 | 2 | 0 | 0 | €26.20 | €35.60 | 35.895% |
| Krystal Biotech | 19 | 0 | 0 | 0 | €159.45 | €184.02 | 15.409% |
| Medpace Holdings Inc | 18 | 0 | 0 | 0 | €303.30 | €408.19 | 34.582% |
| Stoke Therapeutics Inc | 15 | 1 | 0 | 0 | €11.00 | €20.40 | 85.460% |
| Iovance Biotherapeutics Inc. | 17 | 0 | 0 | 0 | €9.11 | €25.20 | 176.650% |
| Personalis Inc | 11 | 1 | 0 | 0 | €4.65 | €7.29 | 56.724% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €311.00 | €365.97 | 17.674% |
| United Therapeutics | 29 | 1 | 0 | 0 | €318.80 | €341.70 | 7.183% |
| Dentsply Sirona Inc. | 18 | 0 | 0 | 0 | €22.32 | €34.20 | 53.204% |
| Newron Pharmaceut. | 3 | 0 | 0 | 0 | €8.11 | - | - |
| Incyte Corp. | 14 | 2 | 1 | 0 | €59.94 | €76.76 | 28.064% |
| Globus Medical A | 1 | 0 | 0 | 0 | €64.00 | - | - |
| Rewalk Robotics Ltd. | 1 | 4 | 0 | 0 | €5.00 | - | - |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.48 | - | - |
| XOMA Corp. | 9 | 0 | 0 | 0 | €23.80 | €68.62 | 188.320% |
| Precision BioSciences Inc | 8 | 0 | 0 | 0 | €0.35 | €35.86 | 10204.253% |
| Pacira Pharmaceuticals | 22 | 1 | 0 | 0 | €14.60 | €40.02 | 174.110% |
| Rockwell Medical Inc. | 2 | 0 | 0 | 0 | €3.26 | €3.50 | 7.428% |